Position in ABSI
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$492,575
-$125,725 QoQ
Shares Held
42,500
-79.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#102
of 195 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PIER 88 INVESTMENT PARTNERS LLC holds $6,341,408 across 13 Biotechnology names. ABSI ranks #6 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
2,400 | $892,008 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
2,600 | $821,834 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,300 | $698,035 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
8,500 | $665,295 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
79,900 | $627,215 | |
| 6 | ABSI |
Absci Corp
This page
|
42,500 | $492,575 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,300 | $469,224 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,100 | $356,495 |
All Filings in ABSI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $492,575 | 42,500 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $618,300 | 206,100 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $718,242 | 205,800 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $724,067 | 238,180 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $507,395 | 197,430 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $762,211 | 303,670 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $553,370 | 211,210 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $519,978 | 136,120 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $456,517 | 148,220 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $247,477 | 43,570 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||